CN115819802A - A kind of colorless transparent collagen hydrogel and preparation method thereof - Google Patents
A kind of colorless transparent collagen hydrogel and preparation method thereof Download PDFInfo
- Publication number
- CN115819802A CN115819802A CN202211673333.1A CN202211673333A CN115819802A CN 115819802 A CN115819802 A CN 115819802A CN 202211673333 A CN202211673333 A CN 202211673333A CN 115819802 A CN115819802 A CN 115819802A
- Authority
- CN
- China
- Prior art keywords
- acid
- colorless
- collagen
- collagen hydrogel
- transparent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
- C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
- C08J3/075—Macromolecular gels
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/24—Crosslinking, e.g. vulcanising, of macromolecules
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/28—Treatment by wave energy or particle radiation
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K3/00—Use of inorganic substances as compounding ingredients
- C08K3/32—Phosphorus-containing compounds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
- C08K5/04—Oxygen-containing compounds
- C08K5/09—Carboxylic acids; Metal salts thereof; Anhydrides thereof
- C08K5/092—Polycarboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
- C08K5/04—Oxygen-containing compounds
- C08K5/15—Heterocyclic compounds having oxygen in the ring
- C08K5/151—Heterocyclic compounds having oxygen in the ring having one oxygen atom in the ring
- C08K5/1545—Six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
- C08K5/16—Nitrogen-containing compounds
- C08K5/22—Compounds containing nitrogen bound to another nitrogen atom
- C08K5/27—Compounds containing a nitrogen atom bound to two other nitrogen atoms, e.g. diazoamino-compounds
- C08K5/28—Azides
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
- C08K5/16—Nitrogen-containing compounds
- C08K5/29—Compounds containing one or more carbon-to-nitrogen double bonds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
- C08K5/16—Nitrogen-containing compounds
- C08K5/34—Heterocyclic compounds having nitrogen in the ring
- C08K5/3412—Heterocyclic compounds having nitrogen in the ring having one nitrogen atom in the ring
- C08K5/3415—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
- C08K5/36—Sulfur-, selenium-, or tellurium-containing compounds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
- C08K5/36—Sulfur-, selenium-, or tellurium-containing compounds
- C08K5/41—Compounds containing sulfur bound to oxygen
- C08K5/42—Sulfonic acids; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L89/00—Compositions of proteins; Compositions of derivatives thereof
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
技术领域technical field
本发明涉及一种生物材料及其制备方法,具体涉及一种无色透明胶原水凝胶及其制备方法。The invention relates to a biological material and a preparation method thereof, in particular to a colorless transparent collagen hydrogel and a preparation method thereof.
背景技术Background technique
胶原蛋白是结缔组织主要的结构蛋白,广泛分布于人体骨骼、皮肤、血管、韧带、软骨、肌肉和肌腱等组织、器官中,占动物总蛋白的25%~30%。作为细胞外基质的主要成分,胶原在维持细胞外基质生物学性能和结构完整性方面起重要的作用。胶原本身具有特殊的四级结构,在特定情况下可以自发聚集形成胶原纤维,并进一步形成水凝胶。然而,从色调上看,常规胶原水凝胶存在明显的“白浊”现象,即,胶原水凝胶呈现白色不透明状态,不利于胶原水凝胶在可视性材料、人工角膜等方面的应用。Collagen is the main structural protein of connective tissue. It is widely distributed in tissues and organs such as human bones, skin, blood vessels, ligaments, cartilage, muscles and tendons, accounting for 25% to 30% of the total protein in animals. As the main component of the extracellular matrix, collagen plays an important role in maintaining the biological properties and structural integrity of the extracellular matrix. Collagen itself has a special quaternary structure, which can spontaneously aggregate to form collagen fibers under certain circumstances, and further form hydrogels. However, from the perspective of color tone, conventional collagen hydrogels have obvious "white turbidity", that is, collagen hydrogels are white and opaque, which is not conducive to the application of collagen hydrogels in visibility materials, artificial corneas, etc. .
本发明主要解决胶原水凝胶的“白浊”问题,可制备无色透明胶原水凝胶,增强胶原水凝胶的透光性。The invention mainly solves the "white turbidity" problem of the collagen hydrogel, can prepare the colorless and transparent collagen hydrogel, and enhances the light transmittance of the collagen hydrogel.
发明内容Contents of the invention
本发明提供一种无色透明胶原水凝胶及其制备方法。The invention provides a colorless transparent collagen hydrogel and a preparation method thereof.
一种无色透明胶原水凝胶的制备方法,其中,依次包括如下步骤:A preparation method of a colorless transparent collagen hydrogel, wherein, comprising the following steps in sequence:
(1)将固体胶原材料溶于水中,充分溶解,离心,取上清液;(1) Dissolving the solid collagen material in water, fully dissolving, centrifuging, and taking the supernatant;
(2)通过碱性溶液或酸性溶液调节步骤(1)所得上清液的pH值至5.0-9.0;(2) adjusting the pH value of the supernatant obtained in step (1) to 5.0-9.0 through an alkaline solution or an acidic solution;
(3)在步骤(2)所得溶液中添加特定离子/分子对;(3) adding a specific ion/molecule pair to the solution obtained in step (2);
(4)在步骤(3)所得溶液中加入交联剂;(4) adding a crosslinking agent in the solution obtained in step (3);
(5)在步骤(4)所得溶液中加入保护分子;(5) Adding protective molecules to the solution obtained in step (4);
(6)将步骤(5)所得溶液进行低温辐照处理。(6) The solution obtained in step (5) is subjected to low-temperature irradiation treatment.
本发明一种无色透明胶原水凝胶的制备方法,其中,所述步骤(1)中固体胶原材料选自I型、II型、III型、V型胶原中的一种或两种以上的组合;所述步骤(1)上清液中各种类型胶原的总浓度为大于等于0.01wt.%但小于等于10wt.%。如果胶原总浓度小于0.01wt.%,胶原溶液无法形成水凝胶;如果胶原总浓度大于10wt.%,胶原溶液中胶原分子很容易形成胶原纤维,发生“白浊”无法形成无色透明胶原水凝胶。A method for preparing a colorless transparent collagen hydrogel of the present invention, wherein, in the step (1), the solid collagen material is selected from one or more of type I, type II, type III, and type V collagen Combination; the total concentration of various types of collagen in the supernatant of step (1) is greater than or equal to 0.01wt.% but less than or equal to 10wt.%. If the total collagen concentration is less than 0.01wt.%, the collagen solution cannot form a hydrogel; if the total collagen concentration is greater than 10wt.%, the collagen molecules in the collagen solution are easy to form collagen fibers, and "white turbidity" cannot form a colorless transparent collagen water gel.
本发明一种无色透明胶原水凝胶的制备方法,其中,步骤(2)中所述酸性溶液包括水杨酸、乳酸、硫酸、酒石酸、柠檬酸、磷酸、草酸、乙酸、乙二酸、琥珀酸、盐酸、马来酸、苯甲酸、硝酸、苹果酸、烟酸、磷酸二氢钠和甲酸中的至少一种;所述碱性溶液包括四甲基乙二胺、氢氧化钠、三乙胺、碳酸钠、氢氧化钾、氢氧化钙、氢氧化镁、氨水、磷酸氢二钠和碳酸氢钠中的至少一种。胶原水溶液在pH中性条件下很容易发生“白浊”现象,通过酸性溶液或碱性溶液精确调控胶原水溶液pH值,比如pH=6.9或pH=7.9,确保胶原分子不发生聚集形成胶原纤维。酸性溶液或碱性溶液的浓度范围为0.01M–2M。A kind of preparation method of colorless transparent collagen hydrogel of the present invention, wherein, the acidic solution described in step (2) comprises salicylic acid, lactic acid, sulfuric acid, tartaric acid, citric acid, phosphoric acid, oxalic acid, acetic acid, oxalic acid, At least one of succinic acid, hydrochloric acid, maleic acid, benzoic acid, nitric acid, malic acid, nicotinic acid, sodium dihydrogen phosphate and formic acid; the alkaline solution includes tetramethylethylenediamine, sodium hydroxide, tris At least one of ethylamine, sodium carbonate, potassium hydroxide, calcium hydroxide, magnesium hydroxide, ammonia water, disodium hydrogen phosphate and sodium bicarbonate. Collagen aqueous solution is prone to "white turbidity" phenomenon under neutral pH conditions. The pH value of collagen aqueous solution is precisely adjusted through acidic or alkaline solutions, such as pH=6.9 or pH=7.9, to ensure that collagen molecules do not aggregate to form collagen fibers. Acidic or alkaline solutions range in concentration from 0.01M–2M.
本发明一种无色透明胶原水凝胶的制备方法,其中,所述步骤(3)中特定离子/分子对包括HPO4 2--柠檬酸、HCO3 --柠檬酸、CO3 2--柠檬酸、H2PO4 --柠檬酸、PO4 3--柠檬酸、Ac--柠檬酸、Ac--H+-NH4 +、HAc-Ac-、HAc-Ac--NH4 +、PO4 3--H+-三乙胺、HPO4 2--H+-三乙胺、H2PO4 --H+-三乙胺、PO4 3--HPO4 2-、Tris-HAc、Tris-H2PO4 -、Tris-NH4 +、Tris-H+、Tris-盐酸赖氨酸、Tris-盐酸赖氨酸-乙二胺四醋酸根离子、PO4 3--H2PO4 -、HPO4 2--H2PO4 -、HPO4 2--NH4 +、H2PO4 --HCO3 -、H2PO4 --CO3 2-、NH4 +-NH3中的至少一种。通过特定离子/分子对调控胶原水溶液的离子环境,阻止胶原分子自组装形成胶原纤维,保持胶原水溶液的均质流动性,从而阻止发生“白浊”现象。特定离子/分子对的浓度范围为0.1M–10M。A method for preparing a colorless transparent collagen hydrogel of the present invention, wherein the specific ion/molecular pair in the step (3) includes HPO 4 2- -citric acid, HCO 3 - -citric acid, CO 3 2- - Citric acid, H 2 PO 4 - -citric acid, PO 4 3- -citric acid, Ac - -citric acid, Ac - -H + -NH 4 + , HAc-Ac - , HAc-Ac - -NH 4 + , PO 4 3- -H + -triethylamine, HPO 4 2- -H + -triethylamine, H 2 PO 4 - -H + -triethylamine, PO 4 3- -HPO 4 2- , Tris-HAc , Tris-H 2 PO 4 - , Tris-NH 4 + , Tris-H + , Tris-lysine hydrochloride, Tris-lysine hydrochloride-EDTA ion, PO 4 3- -H 2 PO 4 - , HPO 4 2- -H 2 PO 4 - , HPO 4 2- -NH 4 + , H 2 PO 4 - -HCO 3 - , H 2 PO 4 - -CO 3 2- , NH 4 + -NH 3 at least one of the Regulate the ionic environment of collagen aqueous solution through specific ion/molecule pairs, prevent collagen molecules from self-assembling to form collagen fibers, and maintain the homogeneous fluidity of collagen aqueous solution, thereby preventing the occurrence of "white turbidity". The concentration range of specific ion/molecule pairs is 0.1M–10M.
本发明一种无色透明胶原水凝胶的制备方法,其中,所述步骤(4)中交联剂包括NHS酯、磺酰氯、酸酐、氟苯基酯、原花青素、京尼平、醛、异硫氰酸酯、异氰酸酯、酰基叠氮化物、环氧化物、芳基卤化物、酰亚胺酯、碳二亚胺中的至少一种。交联剂的浓度范围为0.0001%-5%。A preparation method of a colorless transparent collagen hydrogel of the present invention, wherein, in the step (4), the crosslinking agent includes NHS ester, sulfonyl chloride, acid anhydride, fluorophenyl ester, proanthocyanidin, genipin, aldehyde, iso At least one of thiocyanates, isocyanates, acyl azides, epoxides, aryl halides, imide esters, and carbodiimides. The concentration of the crosslinking agent ranges from 0.0001% to 5%.
本发明一种无色透明胶原水凝胶的制备方法,其中,所述步骤(5)中保护分子包括十二烷基硫酸钠、十二烷基苯磺酸钠、吐温、曲拉通、乙二醇、苯丙氨酸、脯氨酸、卵磷脂、谷氨酸、赖氨酸、半胱氨酸、芒果苷、甘氨酸、天冬氨酸、正丁醇、丙二醇、乙二胺四乙酸钠盐、硬脂酸、司盘、甘油和明胶中的至少一种。加入保护分子主要为了减弱辐照处理对胶原分子活性的影响。保护分子的浓度范围为1%-50%。A kind of preparation method of colorless transparent collagen hydrogel of the present invention, wherein, in described step (5), protection molecule comprises sodium lauryl sulfate, sodium dodecylbenzenesulfonate, Tween, triton, Ethylene glycol, phenylalanine, proline, lecithin, glutamic acid, lysine, cysteine, mangiferin, glycine, aspartic acid, n-butanol, propylene glycol, EDTA At least one of sodium salt, stearic acid, span, glycerin and gelatin. The main purpose of adding protective molecules is to weaken the impact of irradiation treatment on the activity of collagen molecules. The concentration of the protective molecule ranges from 1% to 50%.
本发明一种无色透明胶原水凝胶的制备方法,其中,所述步骤(6)中低温辐照处理的低温范围为-20–5℃。采用低温条件主要为了减弱辐照处理对胶原分子活性的影响。A method for preparing a colorless transparent collagen hydrogel of the present invention, wherein the low temperature range of the low temperature irradiation treatment in the step (6) is -20-5°C. The low temperature condition is mainly used to weaken the influence of irradiation treatment on the activity of collagen molecules.
使用本发明任意一种无色透明胶原水凝胶的制备方法所制备的无色透明胶原水凝胶。The colorless and transparent collagen hydrogel prepared by using any one of the preparation methods of the colorless and transparent collagen hydrogel of the present invention.
本发明一种无色透明胶原水凝胶,其中,所述无色透明胶原水凝胶的浊度范围为0.01×104-2×104NTU。The present invention is a colorless and transparent collagen hydrogel, wherein the turbidity range of the colorless and transparent collagen hydrogel is 0.01×10 4 -2×10 4 NTU.
本发明的有益效果:在胶原分子形成胶原水凝胶过程中,胶原分子会自组装形成胶原纤维,形成的胶原水凝胶通常呈白色不透明状态,导致胶原水凝胶无法用于可视性材料、人工角膜等方面。为了增强胶原水凝胶的透明度,本发明一种无色透明胶原水凝胶的制备方法中主要通过精确调控胶原溶液的pH值和添加特定离子/分子对发生协调作用,平衡胶原分子的表面电荷,增强溶液中的离子强度等,从而尽可能降低胶原分子的自组装行为;在此基础上加入合适的交联剂使胶原分子缓慢温和发生交联反应,避免快速交联形成更多胶原纤维,从而避免胶原水凝胶透明度降低。为了进一步满足无色透明胶原水凝胶在医疗器械中的灭菌灭活要求,避免辐照处理对无色透明胶原水凝胶中胶原分子的影响而导致透明度降低,本发明制备方法中进一步增加了添加保护分子和低温处理的步骤,尽可能减少辐照处理对胶原分子的影响。通过以上步骤,可以制备稳定的无色透明胶原水凝胶。Beneficial effects of the present invention: in the process of collagen molecules forming collagen hydrogels, collagen molecules self-assemble to form collagen fibers, and the formed collagen hydrogels are usually white and opaque, which makes collagen hydrogels unable to be used as visible materials , artificial cornea, etc. In order to enhance the transparency of the collagen hydrogel, in the preparation method of a colorless and transparent collagen hydrogel of the present invention, the pH value of the collagen solution and the addition of specific ion/molecule pairs are coordinated to balance the surface charge of the collagen molecules. , enhance the ionic strength in the solution, etc., so as to reduce the self-assembly behavior of collagen molecules as much as possible; on this basis, add a suitable cross-linking agent to make the collagen molecules cross-link slowly and gently, and avoid rapid cross-linking to form more collagen fibers. Thereby avoiding the reduction of the transparency of the collagen hydrogel. In order to further meet the sterilization and inactivation requirements of the colorless and transparent collagen hydrogel in medical devices, and avoid the influence of radiation treatment on the collagen molecules in the colorless and transparent collagen hydrogel to reduce the transparency, further increase in the preparation method of the present invention Steps of adding protective molecules and low temperature treatment were added to minimize the impact of irradiation treatment on collagen molecules. Through the above steps, a stable colorless and transparent collagen hydrogel can be prepared.
附图说明Description of drawings
图1为胶原水凝胶透光性效果图(图1A是实施例1样品,图1B是实施例2样品,图1C是实施例3样品,图1D是实施例4样品,图1E是实施例5样品,图1F是对比例1样品,图1G是对比例2样品、图1H是对比例3样品,图1I是对比例4样品、图1J是对比例5样品)。Fig. 1 is a collagen hydrogel light transmittance effect figure (Fig. 1A is the sample of embodiment 1, Fig. 1B is the sample of embodiment 2, Fig. 1C is the sample of embodiment 3, Fig. 1D is the sample of embodiment 4, Fig. 1E is the sample of embodiment 5 samples, Fig. 1F is the sample of comparative example 1, Fig. 1G is the sample of comparative example 2, Fig. 1H is the sample of comparative example 3, Fig. 1I is the sample of comparative example 4, Fig. 1J is the sample of comparative example 5).
具体实施方式Detailed ways
实施例1Example 1
一种无色透明胶原水凝胶的制备,其中,依次包括如下步骤:A kind of preparation of colorless transparent collagen hydrogel, wherein, comprises the following steps successively:
(1)将1g I型胶原溶于100mL水中,充分溶解,离心,取上清液;(1) Dissolve 1g type I collagen in 100mL water, fully dissolve, centrifuge, and take the supernatant;
(2)通过1M氢氧化镁溶液或0.1M乙酸溶液调节步骤(1)所得上清液的pH值至7.8;(2) adjusting the pH value of the supernatant obtained in step (1) to 7.8 by 1M magnesium hydroxide solution or 0.1M acetic acid solution;
(3)在步骤(2)所得溶液中添加特定离子/分子对H2PO4 --柠檬酸,浓度为0.1M;(3) Add a specific ion/molecule pair H 2 PO 4 - -citric acid to the solution obtained in step (2) at a concentration of 0.1M;
(4)在步骤(3)所得溶液中加入0.01%原花青素;(4) Add 0.01% proanthocyanidins to the solution obtained in step (3);
(5)在步骤(4)所得溶液中加入5%正丁醇;(5) add 5% n-butanol in the solution gained in step (4);
(6)将步骤(5)所得溶液在0℃进行电子束辐照处理。(6) The solution obtained in step (5) is subjected to electron beam irradiation treatment at 0°C.
实施例2Example 2
一种无色透明胶原水凝胶的制备,其中,依次包括如下步骤:A kind of preparation of colorless transparent collagen hydrogel, wherein, comprises the following steps successively:
(1)将0.1g II型胶原和0.4g III型胶原溶于100mL水中,充分溶解,离心,取上清液;(1) Dissolve 0.1g type II collagen and 0.4g type III collagen in 100mL water, fully dissolve, centrifuge, and take the supernatant;
(2)通过0.5M氨水溶液或1M草酸溶液调节步骤(1)所得上清液的pH值至7.1;(2) adjusting the pH value of the supernatant obtained in step (1) to 7.1 by 0.5M ammonia solution or 1M oxalic acid solution;
(3)在步骤(2)所得溶液中添加特定离子/分子对Tris-H2PO4 -,浓度为1M;(3) Adding a specific ion/molecule pair Tris-H 2 PO 4 − to the solution obtained in step (2) at a concentration of 1M;
(4)在步骤(3)所得溶液中加入0.001%京尼平和1%异氰酸酯;(4) adding 0.001% genipin and 1% isocyanate to the solution obtained in step (3);
(5)在步骤(4)所得溶液中加入1%甘油和2%吐温;(5) add 1% glycerol and 2% Tween in step (4) gained solution;
(6)将步骤(5)所得溶液在-5℃进行Co60辐照处理。(6) The solution obtained in step (5) was irradiated with Co 60 at -5°C.
实施例3Example 3
一种无色透明胶原水凝胶的制备,其中,依次包括如下步骤:A kind of preparation of colorless transparent collagen hydrogel, wherein, comprises the following steps successively:
(1)将20g I型胶原、0.6g III型胶原和5gV型胶原溶于1000mL水中,充分溶解,离心,取上清液;(1) Dissolve 20g of type I collagen, 0.6g of type III collagen and 5g of type V collagen in 1000mL of water, fully dissolve, centrifuge, and take the supernatant;
(2)通过0.2M氢氧化钠溶液或1M盐酸溶液调节步骤(1)所得上清液的pH值至6.5;(2) adjusting the pH value of the supernatant obtained in step (1) to 6.5 by 0.2M sodium hydroxide solution or 1M hydrochloric acid solution;
(3)在步骤(2)所得溶液中添加特定离子/分子对Tris-盐酸赖氨酸-乙二胺四醋酸根离子,浓度为2M;(3) Add specific ion/molecule pair Tris-lysine hydrochloride-ethylenediamine tetraacetate ion to the solution obtained in step (2), the concentration is 2M;
(4)在步骤(3)所得溶液中加入1%NHS酯;(4) adding 1% NHS ester to the solution obtained in step (3);
(5)在步骤(4)所得溶液中加入5%乙二醇和10%芒果苷;(5) adding 5% ethylene glycol and 10% mangiferin in the solution obtained in step (4);
(6)将步骤(5)所得溶液在5℃进行γ射线辐照处理。(6) The solution obtained in step (5) is irradiated with gamma rays at 5°C.
实施例4Example 4
一种无色透明胶原水凝胶的制备,其中,依次包括如下步骤:A kind of preparation of colorless transparent collagen hydrogel, wherein, comprises the following steps successively:
(1)将5g II型胶原和5g II型胶原溶于100mL水中,充分溶解,离心,取上清液;(1) Dissolve 5g type II collagen and 5g type II collagen in 100mL water, fully dissolve, centrifuge, and take the supernatant;
(2)通过0.2M碳酸钠、0.01M氢氧化钾或2M乙二酸、1M琥珀酸溶液调节步骤(1)所得上清液的pH值至5.0;(2) adjust the pH value of the supernatant obtained in step (1) to 5.0 by 0.2M sodium carbonate, 0.01M potassium hydroxide or 2M oxalic acid, 1M succinic acid solution;
(3)在步骤(2)所得溶液中添加特定离子/分子对PO4 3--HPO4 2-、H2PO4 --柠檬酸、Tris-H2PO4 -,浓度为分别为0.5M、10M、1M;(3) Add specific ion/molecule pairs PO 4 3- -HPO 4 2- , H 2 PO 4 - -citric acid, and Tris-H 2 PO 4 - to the solution obtained in step (2) at a concentration of 0.5M respectively , 10M, 1M;
(4)在步骤(3)所得溶液中加入0.2%异硫氰酸酯、5%NHS酯和0.5%酰基叠氮化物;(4) Add 0.2% isothiocyanate, 5% NHS ester and 0.5% acyl azide to the solution obtained in step (3);
(5)在步骤(4)所得溶液中加入2%苯丙氨酸、1%曲拉通和50%赖氨酸;(5) add 2% phenylalanine, 1% triton and 50% lysine in step (4) gained solution;
(6)将步骤(5)所得溶液在-20℃进行Co60辐照处理。(6) The solution obtained in step (5) is subjected to Co 60 irradiation treatment at -20°C.
实施例5Example 5
一种无色透明胶原水凝胶的制备,其中,依次包括如下步骤:A kind of preparation of colorless transparent collagen hydrogel, wherein, comprises the following steps successively:
(1)将0.1g II型胶原溶于1000mL水中,充分溶解,离心,取上清液;(1) Dissolve 0.1g type II collagen in 1000mL water, fully dissolve, centrifuge, and take the supernatant;
(2)通过2M四甲基乙二胺、1M磷酸氢二钠溶液或0.1M柠檬酸溶液调节步骤(1)所得上清液的pH值至9.0;(2) adjusting the pH value of the supernatant obtained in step (1) to 9.0 by 2M tetramethylethylenediamine, 1M disodium hydrogen phosphate solution or 0.1M citric acid solution;
(3)在步骤(2)所得溶液中添加特定离子/分子对HAc-Ac-、H2PO4 --CO3 2-、NH4 +-NH3,浓度分别为1M、1M、5M;(3) Add specific ion/molecule pairs HAc-Ac - , H 2 PO 4 - -CO 3 2- , and NH 4 + -NH 3 to the solution obtained in step (2) at concentrations of 1M, 1M, and 5M, respectively;
(4)在步骤(3)所得溶液中加入0.5%磺酰氯和0.5%酰亚胺酯;(4) adding 0.5% sulfonyl chloride and 0.5% imide ester to the solution obtained in step (3);
(5)在步骤(4)所得溶液中加入1%十二烷基苯磺酸钠和5%丙二醇;(5) add 1% sodium dodecylbenzenesulfonate and 5% propylene glycol in step (4) gained solution;
(6)将步骤(5)所得溶液在4℃进行γ射线辐照处理。(6) The solution obtained in step (5) was irradiated with gamma rays at 4°C.
实施例6Example 6
无色透明胶原水凝胶效果比较试验Comparative experiment on the effect of colorless transparent collagen hydrogel
一、对比胶原水凝胶的制备1. Preparation of comparative collagen hydrogels
对比例1:一种胶原水凝胶的制备,其中,依次包括如下步骤:Comparative example 1: the preparation of a collagen hydrogel, wherein, including the following steps in sequence:
(1)将1g I型胶原溶于100mL水中,充分溶解,离心,取上清液;(1) Dissolve 1g type I collagen in 100mL water, fully dissolve, centrifuge, and take the supernatant;
(2)通过1M氢氧化镁溶液或0.1M乙酸溶液调节步骤(1)所得上清液的pH值7.4中性。(2) Adjust the pH value of the supernatant obtained in step (1) to 7.4 to be neutral by using 1M magnesium hydroxide solution or 0.1M acetic acid solution.
对比例2:一种胶原水凝胶的制备,其中,依次包括如下步骤:Comparative example 2: the preparation of a collagen hydrogel, wherein, including the following steps in sequence:
(1)将1g I型胶原溶于100mL水中,充分溶解,离心,取上清液;(1) Dissolve 1g type I collagen in 100mL water, fully dissolve, centrifuge, and take the supernatant;
(2)通过1M氢氧化镁溶液或0.1M乙酸溶液调节步骤(1)所得上清液的pH值至7.8;(2) adjusting the pH value of the supernatant obtained in step (1) to 7.8 by 1M magnesium hydroxide solution or 0.1M acetic acid solution;
(3)将步骤(2)所得溶液在0℃进行电子束辐照处理。(3) The solution obtained in step (2) is subjected to electron beam irradiation treatment at 0°C.
对比例3Comparative example 3
一种无色透明胶原水凝胶的制备,其中,依次包括如下步骤:A kind of preparation of colorless transparent collagen hydrogel, wherein, comprises the following steps successively:
(1)将20g I型胶原、0.6g III型胶原和5gV型胶原溶于1000mL水中,充分溶解,离心,取上清液;(1) Dissolve 20g of type I collagen, 0.6g of type III collagen and 5g of type V collagen in 1000mL of water, fully dissolve, centrifuge, and take the supernatant;
(2)在步骤(1)所得溶液中加入1%NHS酯;(2) Add 1% NHS ester to the solution obtained in step (1);
(3)在步骤(2)所得溶液中加入5%乙二醇和10%芒果苷;(3) adding 5% ethylene glycol and 10% mangiferin in the solution obtained in step (2);
(4)将步骤(3)所得溶液在5℃进行γ射线辐照处理。(4) The solution obtained in step (3) is irradiated with gamma rays at 5°C.
对比例4Comparative example 4
一种无色透明胶原水凝胶的制备,其中,依次包括如下步骤:A kind of preparation of colorless transparent collagen hydrogel, wherein, comprises the following steps successively:
(1)将5g II型胶原和5g II型胶原溶于100mL水中,充分溶解,离心,取上清液;(1) Dissolve 5g type II collagen and 5g type II collagen in 100mL water, fully dissolve, centrifuge, and take the supernatant;
(2)通过0.2M碳酸钠、0.01M氢氧化钾或2M乙二酸、1M琥珀酸溶液调节步骤(1)所得上清液的pH值至5.0;(2) adjust the pH value of the supernatant obtained in step (1) to 5.0 by 0.2M sodium carbonate, 0.01M potassium hydroxide or 2M oxalic acid, 1M succinic acid solution;
(3)在步骤(2)所得溶液中添加特定离子/分子对PO4 3--HPO4 2-、H2PO4 --柠檬酸、Tris-H2PO4 -,浓度为分别为0.5M、10M、1M;(3) Add specific ion/molecule pairs PO 4 3- -HPO 4 2- , H 2 PO 4 - -citric acid, and Tris-H 2 PO 4 - to the solution obtained in step (2) at a concentration of 0.5M respectively , 10M, 1M;
(4)将步骤(3)所得溶液在-20℃进行Co60辐照处理。(4) The solution obtained in step (3) was subjected to Co 60 irradiation treatment at -20°C.
对比例5Comparative example 5
一种无色透明胶原水凝胶的制备,其中,依次包括如下步骤:A kind of preparation of colorless transparent collagen hydrogel, wherein, comprises the following steps successively:
(1)将0.1g II型胶原溶于1000mL水中,充分溶解,离心,取上清液;(1) Dissolve 0.1g type II collagen in 1000mL water, fully dissolve, centrifuge, and take the supernatant;
(2)通过2M四甲基乙二胺、1M磷酸氢二钠溶液或0.1M柠檬酸溶液调节步骤(1)所得上清液的pH值至9.0;(2) adjusting the pH value of the supernatant obtained in step (1) to 9.0 by 2M tetramethylethylenediamine, 1M disodium hydrogen phosphate solution or 0.1M citric acid solution;
(3)将步骤(2)所得溶液在4℃进行γ射线辐照处理。(3) The solution obtained in step (2) was irradiated with gamma rays at 4°C.
二、效果试验对比2. Effect test comparison
(1)胶原水凝胶浊度测试:胶原水凝胶的浊度在浊度仪(TZD-BZ-905,SuzhouDiagVita Technology Co.,Ltd.)上观察,波长为625nm。测试结果见表1。胶原水凝胶透光性效果图见图1,其中,图1A是实施例1样品,图1B是实施例2样品,图1C是实施例3样品,图1D是实施例4样品,图1E是实施例5样品,图1F是对比例1样品,图1G是对比例2样品、图1H是对比例3样品,图1I是对比例4样品、图1J是对比例5样品。(1) Collagen hydrogel turbidity test: The turbidity of collagen hydrogel was observed on a turbidimeter (TZD-BZ-905, Suzhou DiagVita Technology Co., Ltd.) with a wavelength of 625 nm. The test results are shown in Table 1. Collagen hydrogel light transmittance effect diagram is shown in Figure 1, wherein, Figure 1A is the sample of Example 1, Figure 1B is the sample of Example 2, Figure 1C is the sample of Example 3, Figure 1D is the sample of Example 4, and Figure 1E is the sample of Example 2 Example 5 sample, Figure 1F is the sample of Comparative Example 1, Figure 1G is the sample of Comparative Example 2, Figure 1H is the sample of Comparative Example 3, Figure 1I is the sample of Comparative Example 4, and Figure 1J is the sample of Comparative Example 5.
表1胶原水凝胶浊度测试Table 1 Collagen hydrogel turbidity test
由表1可知,在实施例1-5中胶原水凝胶浊度很低,图1A中实施例1的胶原水凝胶非常透明,可以清晰观察到材料底部的文字,同样的,图1B-1E中胶原水凝胶透明度也很高,可以透过胶原水凝胶看到注射器刻度值;而对比例1-5中胶原水凝胶的浊度很大,图1F中胶原水凝胶非常浑浊,无法观察到材料底部的文字,同样的,图1G-1J中胶原水凝胶非常模糊,透光性很差,基本不能看到注射器刻度值。It can be seen from Table 1 that the turbidity of the collagen hydrogel in Examples 1-5 is very low, and the collagen hydrogel in Example 1 in Figure 1A is very transparent, and the text at the bottom of the material can be clearly observed. Similarly, Figure 1B- The transparency of the collagen hydrogel in 1E is also very high, and the scale value of the syringe can be seen through the collagen hydrogel; while the turbidity of the collagen hydrogel in Comparative Examples 1-5 is very large, and the collagen hydrogel in Figure 1F is very turbid , the text on the bottom of the material cannot be observed. Similarly, the collagen hydrogel in Fig. 1G-1J is very blurred, and the light transmission is very poor, and the scale value of the syringe can hardly be seen.
本发明一种无色透明胶原水凝胶的制备方法中主要通过精确调控胶原溶液的pH值和添加特定离子/分子对发生协调作用,平衡胶原分子的表面电荷,增强溶液中的离子强度等,从而尽可能降低胶原分子的自组装行为;在此基础上加入合适的交联剂使胶原分子缓慢温和发生交联反应,避免快速交联形成更多胶原纤维,从而避免胶原水凝胶透明度降低。为了进一步满足无色透明胶原水凝胶在医疗器械中的灭菌灭活要求,避免辐照处理对无色透明胶原水凝胶中胶原分子的影响而导致透明度降低,本发明制备方法中进一步增加了添加保护分子和低温处理的步骤,尽可能减少辐照处理对胶原分子的影响。通过以上步骤,可以制备稳定的无色透明胶原水凝胶。In the preparation method of a colorless and transparent collagen hydrogel of the present invention, the pH value of the collagen solution and the addition of specific ions/molecules are coordinated to balance the surface charge of the collagen molecules and enhance the ionic strength in the solution. In order to reduce the self-assembly behavior of collagen molecules as much as possible; on this basis, adding a suitable cross-linking agent makes the collagen molecules undergo a slow and gentle cross-linking reaction, avoiding rapid cross-linking to form more collagen fibers, thereby avoiding the reduction of the transparency of the collagen hydrogel. In order to further meet the sterilization and inactivation requirements of the colorless and transparent collagen hydrogel in medical devices, and avoid the impact of radiation treatment on the collagen molecules in the colorless and transparent collagen hydrogel, resulting in a decrease in transparency, the preparation method of the present invention further increases Steps of adding protective molecules and low temperature treatment were added to minimize the impact of irradiation treatment on collagen molecules. Through the above steps, a stable colorless and transparent collagen hydrogel can be prepared.
以上所述的实施例仅仅是对本发明的优选实施方式进行描述,在不脱离本发明设计精神的前提下,本领域普通技术人员对本发明的技术方案做出的各种变形和改进,均应落入本发明权利要求书确定的保护范围内。The above-mentioned embodiment is only a description of the preferred implementation of the present invention. Without departing from the design spirit of the present invention, various deformations and improvements made by those skilled in the art to the technical solution of the present invention shall fall within the scope of the present invention. Into the scope of protection determined by the claims of the present invention.
Claims (10)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211673333.1A CN115819802A (en) | 2022-12-26 | 2022-12-26 | A kind of colorless transparent collagen hydrogel and preparation method thereof |
PCT/CN2023/140520 WO2024140395A1 (en) | 2022-12-26 | 2023-12-21 | Colorless and transparent collagen hydrogel and preparation method therefor |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211673333.1A CN115819802A (en) | 2022-12-26 | 2022-12-26 | A kind of colorless transparent collagen hydrogel and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115819802A true CN115819802A (en) | 2023-03-21 |
Family
ID=85518218
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211673333.1A Pending CN115819802A (en) | 2022-12-26 | 2022-12-26 | A kind of colorless transparent collagen hydrogel and preparation method thereof |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN115819802A (en) |
WO (1) | WO2024140395A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024140395A1 (en) * | 2022-12-26 | 2024-07-04 | 深圳钧兴生物科技有限公司 | Colorless and transparent collagen hydrogel and preparation method therefor |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120321585A1 (en) * | 2009-09-30 | 2012-12-20 | University Of Ottawa | Crosslinked Hydrogels and Related Method of Preparation |
CN109762184A (en) * | 2019-02-12 | 2019-05-17 | 河北考力森生物科技有限公司 | A kind of preparation method of collagen hydrogels |
CN112354013A (en) * | 2020-10-26 | 2021-02-12 | 杜明春 | Bionic collagen aqueous solution and preparation method and use method thereof |
CN114392389A (en) * | 2022-01-21 | 2022-04-26 | 深圳钧兴生物科技有限公司 | Irradiated biological material aqueous solution and preparation method and use method thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101132818A (en) * | 2004-08-13 | 2008-02-27 | 渥太华健康研究所 | Ophthalmic devices and related methods and compositions |
CN103333508A (en) * | 2013-06-28 | 2013-10-02 | 陕西巨子生物技术有限公司 | Collagen hydrogel for injection and preparation method thereof |
CN109957150A (en) * | 2017-12-25 | 2019-07-02 | 成都昕才医药科技有限公司 | A kind of preparation method of temperature-sensitive hydrogel precursor |
CN115819802A (en) * | 2022-12-26 | 2023-03-21 | 深圳钧兴生物科技有限公司 | A kind of colorless transparent collagen hydrogel and preparation method thereof |
-
2022
- 2022-12-26 CN CN202211673333.1A patent/CN115819802A/en active Pending
-
2023
- 2023-12-21 WO PCT/CN2023/140520 patent/WO2024140395A1/en unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120321585A1 (en) * | 2009-09-30 | 2012-12-20 | University Of Ottawa | Crosslinked Hydrogels and Related Method of Preparation |
CN109762184A (en) * | 2019-02-12 | 2019-05-17 | 河北考力森生物科技有限公司 | A kind of preparation method of collagen hydrogels |
CN112354013A (en) * | 2020-10-26 | 2021-02-12 | 杜明春 | Bionic collagen aqueous solution and preparation method and use method thereof |
CN114392389A (en) * | 2022-01-21 | 2022-04-26 | 深圳钧兴生物科技有限公司 | Irradiated biological material aqueous solution and preparation method and use method thereof |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024140395A1 (en) * | 2022-12-26 | 2024-07-04 | 深圳钧兴生物科技有限公司 | Colorless and transparent collagen hydrogel and preparation method therefor |
Also Published As
Publication number | Publication date |
---|---|
WO2024140395A1 (en) | 2024-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zhang et al. | Factors affecting thermal stability of collagen from the aspects of extraction, processing and modification | |
DE69031483T2 (en) | Process for the cross-linking of collagen and product produced thereby | |
EP1419792A1 (en) | Glycosaminoglycan-polycation complex crosslinked by polyfunctional crosslinking agent and process for producing the same | |
Ishikawa et al. | Morphological and biochemical analyses on fibroblasts and self‐produced collagens in a novel three‐dimensional culture | |
BG62915B1 (en) | Biocompatible hydrogel | |
WO2024140395A1 (en) | Colorless and transparent collagen hydrogel and preparation method therefor | |
Demeter et al. | Highly elastic superabsorbent collagen/PVP/PAA/PEO hydrogels crosslinked via e-beam radiation | |
BR112013018508B1 (en) | METHOD FOR PREPARING A COLLAGEN GEL RETICULATED BY RADIATION | |
JPH01111008A (en) | Production of collagen tissue structure and said structure | |
CN113082295B (en) | A skin-derived acellular matrix-derived scaffold and its construction method | |
CN110812529A (en) | Injectable hydrogel and preparation method thereof | |
Caruso et al. | Functional evaluation of collagen fiber scaffolds for ACL reconstruction: cyclic loading in proteolytic enzyme solutions | |
Zheng et al. | Anti-calcification potential of collagen based biological patch crosslinked by epoxidized polysaccharide | |
US7741454B2 (en) | Biological low-molecular-weight derivatives | |
CN115887742A (en) | Preparation method of antibacterial functional collagen-based injectable self-healing hydrogel | |
CN114478829B (en) | Hyaluronic acid crosslinked active material composition, preparation method and application | |
Li et al. | Load-bearing columns inspired fabrication of ductile and mechanically enhanced BSA hydrogels | |
CN108295029A (en) | A kind of injection Multifunctional composite water gel and preparation method thereof | |
Leone et al. | Sodium hyaluronate-g-2-((N-(6-aminohexyl)-4-methoxyphenyl) sulfonamido)-N-hydroxyacetamide with enhanced affinity towards MMP12 catalytic domain to be used as visco-supplement with increased degradation resistance | |
Kim et al. | Preparation and properties of collagen/modified hyaluronic acid hydrogel for biomedical application | |
Li et al. | Promoting tissue repair using deferoxamine nanoparticles loaded biomimetic gelatin/HA composite hydrogel | |
CN106620661A (en) | Application method of glycerol to protection of triple-helical structures of type-I collagen | |
Tenchurin et al. | Modification of non-woven materials based on sodium alginate for tissue-engineering | |
Forrest et al. | Comparative studies on the insoluble collagens of guinea-pig dermis and dermal scar tissue | |
CN107043467B (en) | A kind of photocrosslinkable hydrogel and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |